Skip to main content

Table 4 Intra-block concordance (OPA; PPA; NPA) in PD-L1 classification of NSCLC samples at various applied cut-offs

From: Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay

Applied cut-off

OPA

% (lower 95% CI)

PPA

% (lower 95% CI)

NPA

% (lower 95% CI)

TC PD-L1 staining

  ≥ 50%

97.0 (94.2)

92.2 (84.3)

99.3 (96.6)

  ≥ 25%

98.5 (96.2)

96.7 (91.6)

100.0 (97.3)

  ≥ 10%

96.5 (93.5)

95.3 (90.4)

97.8 (93.4)

  ≥ 1%

91.0 (86.9)

96.2 (92.1)

81.4 (72.1)

IC PD-L1 staining

  ≥ 50%

95.5 (92.3)

14.3 (0.7)

98.4 (96.0)

  ≥ 25%

86.5 (81.9)

17.9 (7.3)

97.7 (94.8)

  ≥ 10%

78.5 (73.2)

78.1 (71.9)

79.6 (67.8)

  ≥ 1%

80.5 (75.3)

81.6 (75.6)

77.1 (64.9)

  1. 200 NSCLC cases (two sections were scored for each case)
  2. CI confidence interval, IC tumor-infiltrating immune cell, NPA negative percentage agreement, NSCLC non-small cell lung cancer, OPA overall percentage agreement, PD-L1 programmed cell death ligand-1, PPA positive percentage agreement, TC tumor cell